Clinical trials have demonstrated the usefulness of antiplatelet agents, percutaneous
coronary intervention, and glycoprotein (GP) IIb/IIIa inhibitors in patients with acute coronary …

Objectives: This study sought to compare use of evidence-based secondary preventive
medications after coronary bypass surgery (CABG) and percutaneous coronary intervention …

Acute coronary syndromes (ACS), which include unstable angina and myocardial infarction
(MI) with or without ST-segment elevation, are life-threatening disorders that remain a …

Background There are conflicting data regarding the relationship between the number of
modifiable traditional risk factors and prognosis in acute coronary syndromes (ACS). This …

Importance The use of evidence-based medication therapy in patients after acute
myocardial infarction (AMI) improves long-term prognosis, yet the current rates of adherence …

Despite improvement in primary prevention1 and treatment, 2 acute myocardial infarction
remains the chief cause of death in the United States and most developed countries. Almost …

Background The extent to which national health quality improvement initiatives have altered
reported treatment gaps among patients with non–ST-segment elevation acute coronary …

Objective To synthesize current evidence on medication adherence rates and associated
risk factors in patients after an acute coronary syndrome (ACS). Methods A systematic …

Background: Medication adherence is important to improve the long-term outcomes after
acute myocardial infarction (MI). We hypothesized that there is significant variation among …

OBJECTIVE: To describe the incidence of adverse drug events (ADEs), preventable ADEs,
and ameliorable ADEs occurring after hospital discharge and their associated risk factors …